We also found that SP1 could regulate the expression of ANRIL.<h4>Conclusion</h4>Our results suggest that lncRNA ANRIL, as a growth regulator, may serve as a new biomarker and target for therapy in HCC. The gene discussed is CDKN2B-AS1; the disease is hepatocellular carcinoma.